Related references
Note: Only part of the references are listed.Soluble CD36 and Risk Markers of Insulin Resistance and Atherosclerosis Are Elevated in Polycystic Ovary Syndrome and Significantly Reduced During Pioglitazone Treatment
Dorte Glintborg et al.
DIABETES CARE (2008)
Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma - A novel marker of insulin resistance
Aase Handberg et al.
CIRCULATION (2006)
Inflammation and insulin resistance
Steven E. Shoelson et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Inflammation and the etiology of type 2 diabetes
A Sjoholm et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2006)
Analysis of gene and protein expression during monocyte-macrophage differentiation and cholesterol loading -: cDNA and protein array study
TT Tuomisto et al.
ATHEROSCLEROSIS (2005)
The inflammatory response is an integral part of the stress response: Implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X
PH Black
BRAIN BEHAVIOR AND IMMUNITY (2003)
Insulin resistance and chronic cardiovascular inflammatory syndrome
JM Fernández-Real et al.
ENDOCRINE REVIEWS (2003)
Insulin resistance, inflammation, and serum fatty acid composition
JM Fernández-Real et al.
DIABETES CARE (2003)
CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity
JM Fernández-Real et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Increased expression of a scavenger receptor (CD36) in monocytes from subjects with Type 2 diabetes
MJ Sampson et al.
ATHEROSCLEROSIS (2003)
A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation
E Griffin et al.
NATURE MEDICINE (2001)
CD36 and atherosclerosis
RL Silverstein et al.
CURRENT OPINION IN LIPIDOLOGY (2000)
Share Paper
